Home › Squamous Cell Carcinoma
Pag-aaral pangklinika para sa Squamous Cell Carcinoma na nagre-recruit sa U.S.
51 pag-aaral para sa Squamous Cell Carcinoma ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Pittsburgh, PA10 pag-aaral
- Boston, MA8 pag-aaral
- Los Angeles, CA8 pag-aaral
- Nashville, TN7 pag-aaral
- Houston, TX7 pag-aaral
- New York City, NY7 pag-aaral
- Atlanta, GA5 pag-aaral
- Washington, DC4 pag-aaral
- Queens, NY4 pag-aaral
- Tampa, FL4 pag-aaral
- Durham, NC4 pag-aaral
- Arlington, VA4 pag-aaral
- Orlando, FL4 pag-aaral
- Dallas, TX4 pag-aaral
- Indianapolis, IN3 pag-aaral
- Chicago, IL3 pag-aaral
- Rochester, NY3 pag-aaral
- Baltimore, MD3 pag-aaral
- Charleston, SC3 pag-aaral
- San Diego, CA3 pag-aaral
- Philadelphia, PA3 pag-aaral
- St. Louis, MO3 pag-aaral
- Staten Island, NY3 pag-aaral
Ayos sa estado
- California12 pag-aaral
- Florida11 pag-aaral
- Georgia5 pag-aaral
- Illinois4 pag-aaral
- Indiana3 pag-aaral
- Maryland4 pag-aaral
- Massachusetts8 pag-aaral
- Missouri3 pag-aaral
- New York15 pag-aaral
- North Carolina5 pag-aaral
- Ohio5 pag-aaral
- Pennsylvania13 pag-aaral
- South Carolina4 pag-aaral
- Tennessee7 pag-aaral
- Texas12 pag-aaral
- Virginia6 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
Nagre-recruitPhase 3
Edad 60 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT04892173Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06047379Intratumoral N17350 in Advanced Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07339176Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06736379Immunotherapy With Chemotherapy and Chemoradiation for Advanced Squamous Cancer of Nasal Cavity / Paranasal Sinuses (I-NAPA)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT05027633Effects of Infusion Timing on Treatment Response in Solid Tumors
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07630168Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07513389A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06561685A Study of IDP-001 in Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07602842Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
Nagre-recruitPhase 2
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT04915183T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
Nagre-recruitPhase 2
Edad 18 hanggang 72 · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT02133196Toripalimab With Chemotherapy for Sinus Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT06940180Machine Learning Analysis of Two-photon Fluorescence Microscopy of Dermatologic Biopsies
Nagre-recruit
Lahat ng edad · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT07682831Two-photon Fluorescence Microscopy of Dermatologic Biopsies
Nagre-recruit
Lahat ng edad · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT07773688A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT07115043Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT)
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT07241585A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT05859074Reflectance Confocal Microscopy of Oral Cancers in Vivo: a Preliminary Trial Comparing Intra-oral Imaging With Pathology
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT02507141Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT06819228Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
Nagre-recruitMaagang Phase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT07628634The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT07285044Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT04198766Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 21, 2026 · NCT05388773Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 15, 2026 · NCT06615635PDT For Induction Therapy For Head And Neck Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 14, 2026 · NCT07214987Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.